
Cancer News
Does adding ribociclib to adjuvant endocrine therapy in early breast cancer reduce recurrence?
| August 5, 2026
An exploratory evaluation published in JAMA Oncology examined the long-lasting efficiency and safety and security of adjuvant ribociclib plus a nonsteroidal aromatase inhibitor in patients with hormone receptor–
Read More



